Market Tracker

09/27 5:16pm ET

Redhill Biopharma Ltd (NASDAQ:RDHL)

14.69
Delayed Data
As of 3:59pm ET
 +0.11 / +0.75%
Today’s Change
8.10
Today|||52-Week Range
16.54
+14.05%
Year-to-Date
No recent news for Redhill Biopharma Ltd.

Today’s Trading

Previous close14.58
Today’s open14.70
Day’s range14.51 - 14.83
Volume50,831
Average volume (3 months)31,013
Market cap$185.9M
Dividend yield--
Data as of 3:59pm ET, 09/27/2016

Growth & Valuation

Earnings growth (last year)-60.54%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-99.96%
P/E ratio--
Price/Sales47,981.20
Price/Book3.08

Competitors

 Today’s
change
Today’s
% change
INNLInnocoll Holdings PL...+0.34+5.58%
--China Health Group I...-0.01-3.38%
VTLVital Therapies Inc+0.15+2.49%
ARGSArgos Therapeutics I...-0.15-3.24%
Data as of 3:59pm ET, 09/27/2016

Financials

Next reporting dateNovember 7, 2016
EPS forecast (this quarter)-$0.54
Annual revenue (last year)$3.0K
Annual profit (last year)-$21.1M
Net profit margin-703,000.00%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Dror Ben-Asher
Chief Operating Officer
Gilead Raday
Corporate headquarters
Tel Aviv, Tel Aviv

Forecasts